MedBlogs

Serelaxin-FDA staff review recommends against Novartis heart failure drug 2014

Posted by Dr.MOHAMMED_ALKHATEEB on Fri, 28 Mar 2014

(0) No of Views (3526)

Member SignIn
Please login to rate

Email
Password


Forgot Password? Sign up now

0 rating

Serelaxin-FDA staff review recommends against Novartis heart failure drug 2014 A drug to treat acute heart failure made by Novartis AG should not be approved because there is insufficient evidence to show it improves symptoms, according to an initial review by the U.S. Food and Drug Administration. The review, posted on the FDA’s website on Tuesday, comes two days ahead of a meeting of outside advisors who will make their own recommendation on whether the drug should be approved. The FDA is not ... Read More

Share this MedBlog

Post Your Comments

This is an open forum for the public. Please follow our Community Guidelines when posting any material. You are welcome to be critical or controversial, but avoid getting personal, abusive or offensive and try to keep your postings brief. All postings are being constantly reviewed for spam and irrelevant material (such as product advertisement or personal advertisements). Any posting that does not conform to our policy and 'Terms of Use' are deleted.
Remember threads are for only feedback and discussion. We will not use this material for publishing papers or advertisements.
You need to be registered with Medwonders to post any item. If you are a New User please register. You will be re-directed back to this page.